be considered when interindividual differences in heart rate exist or when heart rate changes as a consequence of interventions.
The purpose of the present study was to differentiate between the inotropic and the vasodilating effect of enoximone on myocardial oxygen consumption in patients with dilated cardiomyopathy. Therefore, the following questions were addressed: 1) which hemodynamic variables and indexes correlate with measured myocardial oxygen consumption? 2) how does enoximone influence these correlations? and 3) is the influence of enoximone on the relation between hemodynamic variables and myocardial oxygen consumption different from the effects of nitroprusside, which is a vasodilator only?
Enoximone was chosen because it represents a new class of inotropic agents that inhibit phosphodiesterase activity and subsequently increase cyclic adenosine monophosphate. '12,32,33 The hemodynamic effects of enoximone have been investigated in great detail; beneficial effects of intravenous enoximone were shown in patients with advanced cardiac failure.4 [12] [13] [14] 34 The influence of enoximone on myocardial oxygen consumption, however, has not been clarified.12-1'Nitroprusside was chosen because it is a vasodilator only and does not directly affect the myocardium. 35 
Methods Patients
Twenty-two patients with idiopathic dilated cardiomyopathy were included in the study. All patients were in sinus rhythm. Patients with mitral regurgitation exceeding angiographic degree 1 + 36 were excluded from the study. Seventeen were men and five were women. The mean age was 48±9 years, ranging from 24 to 60 years. Nine patients were in New York Heart Association functional Class II, and 13 were in Class III. Idiopathic dilated cardiomyopathy was defined by increased left ventricular end-diastolic volume (>220 ml) and reduced left ventricular ejection fraction (<55%) in the absence of coronary or valvular heart disease or a history of arterial hypertension.
Study Protocol
The study protocol was reviewed and approved by the Ethical Committee of the University Clinics of Freiburg. All patients had given written, informed consent before participating in the study. Cardiac catheterization was performed in the fasting state. All previous medications (digoxin in 11 patients, hydrochlorothiazide-triamterene in two patients, nifedipine in one patient, and propafenone in one patient) were withheld at least 48 hours before catheterization. Left and right heart catheterization was performed by the femoral approach. Catheterization of the coronary sinus was accomplished through a brachial vein. After coronary angiography had been performed, left ventriculography with simultaneous pressure measurement was performed with a Millar microtipped catheter pressure transducer (Houston, Texas). Thereafter myocardial blood flow was measured by the argon method. Blood samples were taken from the aorta and the coronary sinus for oxygen saturation measurements. Cardiac output was measured by the thermodilution technique. Upon completion of basal measurements, the following interventions were performed.
Enoximone was given in 12 patients. Eight were in New York Heart Association functional Class III, and four were in Class 11. Enoximone was administered intravenously at a dose of 1 mg/kg at a rate of 12.5 mg/min while aortic pressure was measured continuously. Five minutes after completion of the enoximone infusion, the aortic pressure was read again. If mean aortic pressure was decreased by more than 15% or was below 75 mm Hg, no additional enoximone was infused. In five patients, an additional dosage of 1 mg/kg was given at the same rate to achieve similar changes in aortic pressure in all patients. Five patients received 2 mg/kg, and seven patients received 1 mg/kg. Fifteen minutes after the infusion of enoximone had been completed, myocardial blood flow and oxygen saturation were repeatedly measured, cardiac output was measured, and left ventriculography with simultaneous pressure measurement was performed. This procedure was used because within 10 minutes after intravenous application of enoximone a stable hemodynamic effect is reached and maintained for 5-6 hours.34 Plasma samples for determining norepinephrine plasma levels were taken from the aorta and the coronary sinus during the control period and after enoximone administration.
Nitroprusside was given to 10 patients. Five patients were in New York Heart Association functional Class III, and five were in Class II. The infusion was begun at a rate of 25 
where S is instantaneous wall stress, P is instantaneous left ventricular pressure, h is instantaneous left ventricular wall thickness, a is major hemiaxis, b is minor hemiaxis; a and b were derived from the calculated volumes by the area-length method. The systolic stress-time integral (STI, 103dynes * sec/ cm2) was calculated by integrating instantaneous stress values from end diastole to end systole. End-diastolic wall stress was defined as the wall stress value at end-diastolic pressure, and endsystolic wall stress was defined as the stress value derived from the cineframe before left ventricular volume increased. Pressure-volume work (PVwork, mm Hg 1/100 g) was calculated as the area of the pressure-volume loop obtained by relating instantaneous pressure to volume every 20 msec and normalizing for 100 g wall mass. Cardiac output was measured by the thermodilution technique, and stroke volume was obtained by dividing cardiac output by heart rate. Mean velocity of circumferential fiber shortening (MVCf, circ/sec) was calculated from the formula: MVCf= (LVEDD -LVESD)/ (LVEDD x LVET), where LVEDD is left ventricular minor diameter at end diastole, LVESD is left ventricular minor diameter at end systole (both derived by the area-length method), and LVET is left ventricular ejection time measured from central aortic tracings. Left ventricular ejection fraction (EF, %) was calculated from the formula: EF=(LVEDV-LVESV/LVEDV), where LVEDV is left ventricular end-diastolic volume, and LVESV is left ventricular end-systolic volume. Bretschneider's formula17,25,26 was calculated as follows: E, (ml O2/min/100 g)=Eo+El +E2+E3+E4
where Eo is 0.7, E1 is 0.03 * t,yt * HR, E2 is (0.0014. LVSP15 . LVET . HR)/(dP/dt)113, E3 is 1.2* 10-5 dP/dt * HR, E4 is 8.0* 10`-9 (dP/dt)'15 . HR, tsyt is QT-duration, HR is heart rate, LVSP is left ventricular peak systolic pressure, LVET MVo2 (ml/min/100 g) or (gllbeat/100 g), myocardial oxygen consumption per minute or per beat; E, (ml/min/100 g), Bretschneider's index; PWI (ml/min/100 g), pressure-work index; STI (103 dynes * sec/cm2), left ventricular systolic stress-time integral; HR (min-1), heart rate; Sm,,x (103 dynes/cm2), left ventricular peak systolic wall stress; PV-work (mm Hg 1/100 g), pressurevolume work; dP/dtm,,a (mm Hg/sec), maximum rate of left ventricular pressure rise; MVCf (circ/sec), mean velocity of circumferential fiber shortening; PVA (mm Hg * ml/100 g), pressure-volume area. myocardial oxygen consumption on the other. Differences in heart rate were taken into account by calculating both myocardial oxygen consumption and hemodynamic variables per beat as well as per minute (Table 5 ). The best correlation was found between myocardial oxygen consumption and systolic stress-time integral (Figure 2 ). Peak systolic wall stress correlated moderately with myocardial oxygen consumption (Figure 3 ). There was no relevant correlation between myocardial oxygen consumption and pressure-volume work, maximum rate of left ventricular pressure rise, or mean velocity of circumferential fiber shortening (Figure 3) . Consideration of pressure-volume work, maximum rate of left ventricular pressure rise, or mean velocity of circumferential fiber shortening did not significantly improve the relation between myocardial oxygen consumption and systolic stress-time integral. When the correlation between myocardial oxygen consumption and systolic stress-time integral obtained from all control and nitroprusside data points was extrapolated to zero stress-time integral, the energy utilization for the nonmechanical activity of the myocardium was 2.55 ml/min/100 g (Figure 2 ). By including stress-time integral and myocardial oxygen consumption data obtained under conditions of enoximone in the regression analysis, we found that they-axis intercept was increased and the slope was decreased, whereas this inclusion reduced the correlation coefficient ( (Figure 4 ). This correlation did not significantly improve when the other variables were taken into account. A significant linear correlation between the decrease of myocardial oxygen consumption and the decrease of systolic stress-time integral was also observed after the administration of enoximone. However, the slope of the regression line was significantly lower under conditions of enoximone (0.51 vs. 1.27, p<0.05), indicating a smaller decrease of myocardial oxygen consumption for a given reduction of stress-time integral with enoximone.
Applying the pressure-work index ( Figure 5 ) and the pressure-volume area ( Figure 6) In the first part of this investigation, the relation between myocardial oxygen consumption and hemodynamic variables in patients with dilated cardiomyopathy was evaluated. The calculations were performed for two different sets of data. The control values of all patients and the values obtained with nitroprusside were included in the first set. This analysis is based on the assumption that nitroprusside has no direct effects on the myocardium. 35 The correlations obtained with these data are considered to represent basal conditions. Second, the data obtained with enoximone were added to the control and nitroprusside values to evaluate any deviation from basal conditions that may result from enoximone. When the predicted myocardial oxygen consumption by the pressure-work index,17 Bretschneider's index,25,26 and the pressure-volume area27 was correlated with measured myocardial oxygen consumption, only moderate correlations were obtained. This is in contrast to the findings in normal dog hearts17,25-27 and may be because left ventricular volume and wall thickness are inadequately considered in these indexes. Consideration of left ventricular geometry may be especially relevant in these patients with enlarged hearts. Of emphasis, the pressure-volume area was calculated by a modification of the method given by Suga,27 assuming the volume-axis intercept, VO, was zero.47
To develop an index that considers left ventricular volume and wall-thickness, the coupling of myocardial oxygen consumption with left ventricular hemodynamic variables, including peak systolic wall stress and systolic stress-time integral, was investigated. The rationale for the performed multiple regression analyses using heart rate, wall stress, and velocity of myocardial contraction was based on experimental data suggesting that they are major determinants of myocardial oxygen consumption'8; the additional influence of external myocardial work on energy consumption is unclear. 48, 49 Consideration of heart rate is relevant for the present analysis because heart rate increased significantly with enoximone but remained unchanged with nitroprusside. The increase in heart rate with enoximone may have resulted from peripheral vasodilation or from direct effects of enoximone on the sinoatrial node.34 Heart rate was taken into account by calculating both myocardial oxygen consumption and hemodynamic variables for one cardiac by heart rate when hemodynamic variables remain constant.
Left ventricular systolic stress-time integral was found to be the major determinant of myocardial oxygen consumption in these patients with dilated cardiomyopathy. Systolic wall stress as a function of pressure, volume, and wall thickness represents the force developed per unit cross-sectional area of myocardium necessary to produce the intraventric- 11.1 ular pressure at the given geometry. In addition to peak wall stress, systolic stress-time integral includes the pattern of stress development and maintenance and therefore describes the entire period of mechanical activity. 29"48'51 This may explain the stronger correlation between myocardial oxygen consumption and stress-time integral compared with peak stress. In contrast to experiments in normal dog hearts,52'53 in these patients, indexes of contraction velocity such as maximum rate of left ventricular pressure rise (isovolumic phase) and mean velocity of circumferential fiber shortening (ejecting phase) were not significantly related to myocardial oxygen consumption. The lack of correlation between pressure-volume work and myocardial oxygen consumption may be because pressure-volume work is reduced relative to stress-time integral in patients with dilated cardiomyopathy.54 Extrapolation of the oxygen consumption-stress-time integral relation to zero stress-time integral yields an intercept of 2.55 ml/ min/100 g, which represents the energy utilization for the nonmechanical activity of the myocardium. Oxygen consumption of the empty beating dog heart was recently reported by Gibbs et a155 to be 3.8 mVmin/100
g at a heart rate of 158 beats/min. After arrest caused by potassium chloride, basal myocardial oxygen consumption was 1.74 ml/min/100 g in this study. Suga et al19 reported a value of 5.24 ml/min/100 g at a rate of 138 beats/min and of 1.47 mllmin/100 g after arrest.
When values obtained during enoximone administration were included, the y-axis intercept of the regression line increased, and the slope decreased, whereas the correlation coefficient was reduced. In Figure 2 , 11 of 12 enoximone values are above the regression line, indicating higher oxygen consumption per unit stress-time integral under conditions of enoximone.
Comparative Effects of Enoximone and Nitroprusside on Myocardial Energetics
To distinguish the energetic consequences of the inotropic and the vasodilating effects of enoximone, the influence of enoximone on myocardial oxygen consumption and hemodynamic variables was compared with the effects of nitroprusside. After the administration of both drugs, there was a significant correlation of the decrease in myocardial oxygen consumption with the decrease in systolic stresstime integral. However, for a given reduction of stress-time integral, the decrease of myocardial oxygen consumption was smaller with enoximone. The diminished savings in oxygen subsequent to reduced systolic stress-time integral reflects the extra energy demand of the inotropic effect of enoximone that masks the energy-saving effect of vasodilation.
Although the pressure-work index and the pressure-volume area were only moderately correlated to myocardial oxygen consumption when absolute values were analyzed, close correlations were obtained when the nitroprusside-induced changes of either index were plotted against the corresponding changes of myocardial oxygen consumption. The better correlations may reflect that absolute values of left ventricular geometry are less relevant when changes in indexes are used. By applying the pressure-work index and the pressure-volume area instead of systolic stress-time integral, we found similar energetic differences between nitroprusside and enoximone.
Because the reduction of preload and afterload was more pronounced with enoximone than with nitroprusside, the question arises whether the energetic changes observed might have been caused by an increase in plasma catecholamines rather than by the direct effects of enoximone on the myocardium. This possibility can be excluded, however, because norepinephrine plasma levels did not significantly change after the administration of enoximone.
Whether myocardial oxygen consumption decreases, increases, or remains unchanged in response to enoximone depends on the degree by which the energetic consequences of peripheral vasodilation offset the increased energy cost of the inotropic effect. In these patients with moderate congestive heart failure, enoximone exerted a pronounced vasodilating effect that compensated for the increased energy demand due to inotropic stimulation. However, because the quantitative response to vasodilation varies with the degrees of heart failure, the presence of peripheral edema and concomitant medication, global myocardial oxygen consumption may increase in another group of patients.56,57 This may also explain the conflicting results of clinical studies on the effect of enoximone on myocardial oxygen consumption per minute in which oxygen consumption decreased by 18%,13 remained unchanged (present study), or increased significantly by 7%12 or 33%,14
External myocardial efficiency that was reduced during basal conditions compared with normal values showed the tendency to increase with nitroprusside and to decrease with enoximone. Efficiency was significantly increased while myocardial oxygen consumption was decreased after enoximone in the study of Amin et al. 13 
Conclusions and Clinical Implications
Left ventricular systolic stress-time integral is the major determinant of myocardial oxygen consumption in patients with dilated cardiomyopathy and moderate congestive heart failure. Vasodilation with nitroprusside or enoximone reduces myocardial oxygen consumption in proportion to the reduction of systolic stress-time integral; however, the amount of oxygen reduction is significantly smaller with enoximone. This indicates that enoximone has both an energy-saving effect due to its vasodilating properties and an energy-consuming effect by inotropically stimulating the myocardium. Measured myocardial oxygen consumption reflects the energetic consequences of both pharmacologic properties of enoximone.
The clinical application of enoximone is harmless in terms of myocardial energy consumption provided the vasodilating and inotropic effects of enoximone are balanced. If, however, the inotropic effect of enoximone becomes dominant, myocardial energy demand increases. This must be considered particularly if an initial vasodilating effect is lost or attenuated during long-term therapy,3 especially in patients with congestive heart failure due to ischemic heart disease. Although the clinical relevance of energy metabolism for the pathogenesis and progression of idiopathic dilated cardiomyopathy is not understood yet, increased energy demand due to inotropic stimulation may have harmful effects7 if mitochondrial or microvascular dysfunctions are present in this disease. 7, 62 
